In 2016 was created HEDA Ventures, which is appeared as VC. The leading representative office of defined VC is situated in the San Jose. The fund was located in North America if to be more exact in United States.
The top activity for fund was in 2017. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in 2-6 deals every year.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the HEDA Ventures, startups are often financed by TSVC, Lilly Ventures, National Institutes of Health. The meaningful sponsors for the fund in investment in the same round are TSVC, ZhenFund, Wisemont Capital. In the next rounds fund is usually obtained by TSVC, ZhenFund, Xilinx.
The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are Health Care, Internet. Among the various public portfolio startups of the fund, we may underline Symic Biomedical, Citcon, Paragon Genomics Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Besides them, we counted 3 critical employees of this fund in our database.
Related Funds
Funds with similar focus
Fund Name | Location |
AFY Partners | France, Lyon, Rhone-Alpes |
Bisque | Mauritius, Moka, Moka |
Eagle Private Capital | Missouri, St Louis, United States |
Gates Ventures | Kirkland, United States, Washington |
Plum Holdings | Montclair, New Jersey, United States |
Serendipity Partners | Norway, Oslo |
SMT (SportsMEDIA Technology) | Durham, North Carolina, United States |
Toolmall.com | China, Hangzhou, Zhejiang |
Y S Capital | India, Maharashtra, Sewri |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Immunowake | $20M | 15 May 2022 | Birmingham, Alabama, United States | ||
LYNK Pharmaceuticals | $50M | 27 Aug 2021 | Hangzhou, Zhejiang, China | ||
Lianchuan Bio | $17M | 28 Jun 2020 | Hangzhou, Zhejiang, China | ||
Citcon | $8M | 16 Apr 2019 | San Jose, California, United States | ||
MuMec | 15 Aug 2018 | Berkeley, California, United States | |||
Paragon Genomics | $8M | 12 Sep 2017 | Hayward, California, United States | ||
Symic Biomedical | $30M | 22 May 2017 | California, United States | ||
Citcon | $4M | 01 Mar 2017 | San Jose, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Immunowake | $20M | 15 May 2022 | Birmingham, Alabama, United States | ||
LYNK Pharmaceuticals | $50M | 27 Aug 2021 | Hangzhou, Zhejiang, China | ||
Lianchuan Bio | $17M | 28 Jun 2020 | Hangzhou, Zhejiang, China | ||
Citcon | $8M | 16 Apr 2019 | San Jose, California, United States | ||
MuMec | 15 Aug 2018 | Berkeley, California, United States | |||
Paragon Genomics | $8M | 12 Sep 2017 | Hayward, California, United States | ||
Symic Biomedical | $30M | 22 May 2017 | California, United States | ||
Citcon | $4M | 01 Mar 2017 | San Jose, California, United States |